<DOC>
	<DOCNO>NCT01049139</DOCNO>
	<brief_summary>This study carry preliminary `` proof concept '' evaluate two type supplemental information would serve adjunct traditional informed consent Human Immunodeficiency Virus ( HIV ) vaccine clinical trial . These compare condition traditional informed consent form use alone . Using four intervention site , participant administer standard HIV vaccine trial consent form . They randomize three condition : 1 ) No supplemental information ; 2 ) Supplemental information 1-sided message ( emphasizes information content relate vaccine trial randomization unproven efficacy vaccine ) ; 3 ) Supplemental information 2-sided message ( acknowledges beliefs odds information content seek neutralize belief counter-argument ) . An interviewer-administered questionnaire ( IAQ ) Part 1 administer traditional HIV vaccine trial inform consent review participant . An IAQ Part 2 administer directly HIV vaccine trial informed consent control condition read supplemental material . Debriefing interview conduct select participant review understand study procedure reaction supplemental material and/or questionnaire . The propose research `` proof concept '' study therefore design test hypothesis . Consequently , formal hypothesis related power calculation detect certain effect size require . Instead , goal enroll appropriate number subject purpose determine feasibility develop large study supplemental information use adjunct informed consent statement HIV vaccine clinical trial provide related descriptive statistic .</brief_summary>
	<brief_title>Preventative Misconception Intervention</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Not know HIV positive self report ; NOTE : HIV test criterion entry . Participants refer HIV test , interested ; A history least one unprotected sexual encounter involve either vaginal anal penetration ( receptive insertive ) male partner 6 month prior enrollment ; Between age 1619 ( inclusive ) time informed consent/assent ; Ability understand write spoken English ; Willing consider enrollment HIV vaccine trial ; Gives inform consent/assent study participation . Anything would impair participant 's ability meet study requirement ( i.e . readily apparent psychiatric symptom ( hallucination , think disorder ) , visibly distraught ( suicidal , homicidal , exhibit violent behavior ) , intoxicated influence alcohol substance time study enrollment* ; *NOTE : Participants visibly influence time consent/enrollment , interview .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>vaccination</keyword>
	<keyword>HIV prevention</keyword>
	<keyword>YMSM</keyword>
	<keyword>youth</keyword>
	<keyword>HIV Preventative Vaccine</keyword>
</DOC>